Guardant Health (GH) Other Accumulated Expenses (2023 - 2024)

Guardant Health (GH) posted Other Accumulated Expenses of $68.3 million for Q4 2024, up 7.67% sequentially from $63.5 million in Q4 2023, and up 7.67% YoY from $63.5 million in Q1 2024.

Guardant Health (GH) Other Accumulated Expenses (2023 - 2024) Analysis & Trends

Guardant Health has reported Other Accumulated Expenses for 2 years, with the latest figure at $68.3 million in Q4 2024.

  • Quarterly Other Accumulated Expenses rose 7.67% year-over-year to $68.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $68.3 million (up 7.67% YoY) and the FY2024 annual result came in at $68.3 million, up 7.67% from the prior year.
  • Other Accumulated Expenses advanced to $68.3 million in Q4 2024 per GH's latest filing, from $63.5 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $68.3 million in Q4 2024 and troughed at $63.5 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Guardant Health 21.59 Bn 20.53 Bn 219.03 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 68.35 Mn
Dec 31, 2023 63.48 Mn